Gain Therapeutics (GANX) Price to Book (2021 - 2026)

Gain Therapeutics has reported Price to Book for 6 years, with the latest figure at 7.79 in Q2 2026.

• On a quarterly basis, Price to Book fell 48.01% year-over-year to 7.79 in Q2 2026; TTM through Jun 2026 was 7.79, a 48.01% decrease from a year earlier, with the FY2025 full-year figure at 5.72, down 28.39% from the prior year.
• Price to Book was 7.79 for Q2 2026 at Gain Therapeutics, up from 5.88 in the prior quarter.
• The five-year high for Price to Book was 14.99 in Q2 2025, with the low at 1.53 in Q1 2022.
• Average Price to Book over 5 years is 5.7, with a median of 5.45 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Price to Book sank 59.09% in 2024, then soared 618.02% in 2025.
• Over 5 years, Price to Book stood at 1.97 in 2022, then surged by 71.43% to 3.38 in 2023, then jumped by 136.42% to 7.98 in 2024, then fell by 28.39% to 5.72 in 2025, then jumped by 36.26% to 7.79 in 2026.
• The last three Price to Book figures came in at 7.79 (Q2 2026), 5.88 (Q1 2026), and 5.72 (Q4 2025), per Business Quant data.